GlobeNewswire: Nanosphere, Inc. Contains the last 10 of 157 releaseshttp://www.globenewswire.com/External?Length=42024-03-19T06:48:50ZGlobeNewswirehttp://www.globenewswire.com/External?Length=4newsdesk@globenewswire.com (NewsDesk)https://www.globenewswire.com/news-release/2016/06/20/849988/0/en/Nanosphere-Announces-Intent-to-Voluntarily-Delist-From-NASDAQ-Capital-Market.html?f=22&fvtc=4&fvtv=7292Nanosphere Announces Intent to Voluntarily Delist From NASDAQ Capital Market2016-06-20T20:01:00Z<![CDATA[NORTHBROOK, Ill., June 20, 2016 (GLOBE NEWSWIRE) -- Nanosphere, Inc. (NASDAQ:NSPH), a company enhancing medicine through targeted molecular diagnostics, today announced that it notified the NASDAQ Capital Market ("NASDAQ") of its intent to file a Form 25 with the Securities and Exchange Commission on or about June 30, 2016, following the expiration of the Tender Offer (as defined below), to initiate the voluntary delisting of the Company's common stock (the "Common Stock") from NASDAQ in anticipation of the closing of the merger of Commodore Acquisition, Inc. (“Merger Sub”), a wholly owned subsidiary of Luminex Corporation, with and into Nanosphere, on or about June 30, 2016.  The official delisting of the Securities will be effective ten days after Nanosphere files the Form 25. ]]>https://www.globenewswire.com/news-release/2016/05/16/840162/0/en/Nanosphere-Announces-First-Quarter-Results.html?f=22&fvtc=4&fvtv=7292Nanosphere Announces First Quarter Results2016-05-16T10:00:00Z<![CDATA[NORTHBROOK, Ill., May 16, 2016 (GLOBE NEWSWIRE) --  Nanosphere, Inc. (NASDAQ:NSPH), a company enhancing medicine through targeted molecular diagnostics, today reported financial results for the first quarter March 31, 2016.]]>https://www.globenewswire.com/news-release/2016/03/03/816577/0/en/Nanosphere-s-Verigene-BC-GP-Decreases-Patient-Length-of-Stay.html?f=22&fvtc=4&fvtv=7292Nanosphere’s Verigene BC-GP Decreases Patient Length of Stay2016-03-03T13:00:00Z<![CDATA[Peer-Reviewed Publication Highlights Five-Day Decrease in Hospital Stay Peer-Reviewed Publication Highlights Five-Day Decrease in Hospital Stay]]>https://www.globenewswire.com/news-release/2016/02/24/813815/0/en/Nanosphere-Announces-Fourth-Quarter-and-Full-Year-2015-Results-2016-Guidance-and-Next-Generation-Verigene-Progress.html?f=22&fvtc=4&fvtv=7292Nanosphere Announces Fourth Quarter and Full Year 2015 Results, 2016 Guidance and Next Generation Verigene Progress2016-02-24T21:01:00Z<![CDATA[Corporate Highlights and Guidance:]]>https://www.globenewswire.com/news-release/2016/02/11/809888/0/en/Nanosphere-to-Announce-Fourth-Quarter-Financial-Results-and-Host-Investor-Call-on-Wednesday-February-24.html?f=22&fvtc=4&fvtv=7292Nanosphere to Announce Fourth Quarter Financial Results and Host Investor Call on Wednesday, February 242016-02-11T13:00:00Z<![CDATA[NORTHBROOK, Ill., Feb. 11, 2016 (GLOBE NEWSWIRE) -- Nanosphere, Inc. (NASDAQ:NSPH), a company enhancing medicine through targeted and flexible molecular diagnostics, announced today that it will report its results for the fourth quarter ended December 30, 2015 after the market close on Wednesday, February 24, 2016.  The company will also hold a live investor conference call and webcast at 5pm Eastern Time.]]>https://www.globenewswire.com/news-release/2016/01/06/799956/0/en/Nanosphere-Announces-Record-Preliminary-Q4-and-Full-Year-2015-Results.html?f=22&fvtc=4&fvtv=7292Nanosphere Announces Record Preliminary Q4 and Full Year 2015 Results2016-01-06T21:01:00Z<![CDATA[NORTHBROOK, Ill., Jan. 06, 2016 (GLOBE NEWSWIRE) -- Nanosphere, Inc. (NASDAQ:NSPH), a company enhancing medicine through targeted molecular diagnostics, today reported preliminary results for the fourth quarter ended December 31, 2015.]]>https://www.globenewswire.com/news-release/2015/12/23/797952/0/en/Verigene-BC-GN-Positioned-to-Provide-Rapid-Diagnosis-of-Phantom-Menace-Superbug.html?f=22&fvtc=4&fvtv=7292Verigene® BC-GN Positioned to Provide Rapid Diagnosis of “Phantom Menace” Superbug2015-12-23T13:00:00Z<![CDATA[NORTHBROOK, Ill., Dec. 23, 2015 (GLOBE NEWSWIRE) -- Nanosphere, Inc. (NASDAQ:NSPH), a company enhancing medicine through targeted and flexible molecular diagnostics, confirms that the Verigene® Gram-Negative Blood Culture Test (BC-GN) is the only FDA-cleared test with the ability to rapidly identify the antibiotic resistance gene associated with a dangerous new superbug.]]>https://www.globenewswire.com/news-release/2015/12/22/797763/0/en/Nanosphere-Inc-Announces-Completion-of-10-Million-Registered-Public-Offering.html?f=22&fvtc=4&fvtv=7292Nanosphere, Inc. Announces Completion of $10 Million Registered Public Offering2015-12-22T21:04:19Z<![CDATA[NORTHBROOK, Ill., Dec. 22, 2015 (GLOBE NEWSWIRE) -- Nanosphere, Inc. (Nasdaq:NSPH), a company enhancing medicine through targeted and flexible molecular diagnostics, today announced the completion of its previously announced public offering of the company’s common stock for total gross proceeds of approximately $10 million. ]]>https://www.globenewswire.com/news-release/2015/12/17/796652/0/en/Nanosphere-Inc-Announces-10-Million-Registered-Public-Offering.html?f=22&fvtc=4&fvtv=7292Nanosphere, Inc. Announces $10 Million Registered Public Offering 2015-12-17T23:32:37Z<![CDATA[NORTHBROOK, Ill., Dec. 17, 2015 (GLOBE NEWSWIRE) -- Nanosphere, Inc. (Nasdaq:NSPH), a company enhancing medicine through targeted and flexible molecular diagnostics, today announced the pricing of a public offering of the company’s common stock with expected total gross proceeds of approximately $10 million.  The offering is expected to close on or about December 22, 2015, subject to satisfaction of customary closing conditions.   ]]>https://www.globenewswire.com/news-release/2015/11/09/785361/10155742/en/Nanosphere-Announces-Record-Q3-2015-Results.html?f=22&fvtc=4&fvtv=7292Nanosphere Announces Record Q3 2015 Results2015-11-09T21:01:00Z<![CDATA[NORTHBROOK, Ill., Nov. 9, 2015 (GLOBE NEWSWIRE) -- Nanosphere, Inc. (Nasdaq:NSPH), a company enhancing medicine through targeted molecular diagnostics, today reported financial and operating results for the third quarter ended September 30, 2015.]]>